Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke Volume | 4 | 2016 | 448 | 0.580 |
Why?
|
| Metabolic Syndrome | 3 | 2016 | 325 | 0.540 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2016 | 366 | 0.490 |
Why?
|
| Heart Failure | 8 | 2018 | 2125 | 0.460 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 114 | 0.460 |
Why?
|
| Echocardiography | 3 | 2016 | 1069 | 0.430 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 500 | 0.410 |
Why?
|
| Heart Atria | 2 | 2005 | 310 | 0.380 |
Why?
|
| Obesity | 2 | 2016 | 2092 | 0.310 |
Why?
|
| Cultural Diversity | 1 | 2008 | 63 | 0.300 |
Why?
|
| Cardiac Volume | 2 | 2005 | 17 | 0.280 |
Why?
|
| Echocardiography, Doppler | 2 | 2005 | 172 | 0.260 |
Why?
|
| Atrial Function, Left | 1 | 2005 | 27 | 0.240 |
Why?
|
| Exercise Therapy | 1 | 2005 | 147 | 0.220 |
Why?
|
| Pergolide | 1 | 2002 | 5 | 0.210 |
Why?
|
| Antiparkinson Agents | 1 | 2002 | 65 | 0.200 |
Why?
|
| Life Style | 1 | 2005 | 397 | 0.200 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2002 | 63 | 0.200 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 234 | 0.180 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 846 | 0.170 |
Why?
|
| Atrial Fibrillation | 1 | 2003 | 623 | 0.130 |
Why?
|
| Stroke | 1 | 2003 | 957 | 0.120 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 174 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 439 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2018 | 364 | 0.120 |
Why?
|
| American Heart Association | 1 | 2016 | 293 | 0.120 |
Why?
|
| Hypertension | 2 | 2016 | 1276 | 0.110 |
Why?
|
| Aged | 9 | 2018 | 18998 | 0.110 |
Why?
|
| Middle Aged | 10 | 2018 | 25885 | 0.100 |
Why?
|
| Sex Factors | 2 | 2008 | 1246 | 0.100 |
Why?
|
| Cardiology | 1 | 2016 | 472 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 73 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 276 | 0.090 |
Why?
|
| Vascular Stiffness | 1 | 2011 | 75 | 0.090 |
Why?
|
| Female | 11 | 2018 | 65361 | 0.080 |
Why?
|
| Male | 11 | 2018 | 59957 | 0.080 |
Why?
|
| Age Factors | 2 | 2008 | 2799 | 0.080 |
Why?
|
| Myocardium | 2 | 2005 | 983 | 0.080 |
Why?
|
| Humans | 15 | 2018 | 122971 | 0.080 |
Why?
|
| Aneurysm, Infected | 1 | 2007 | 25 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2011 | 1317 | 0.070 |
Why?
|
| Sinus of Valsalva | 1 | 2007 | 36 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 58 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 80 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2008 | 4688 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2007 | 241 | 0.070 |
Why?
|
| Aortic Rupture | 1 | 2007 | 118 | 0.070 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2005 | 3 | 0.060 |
Why?
|
| Texas | 2 | 2018 | 3542 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2005 | 37 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1346 | 0.060 |
Why?
|
| Diet, Fat-Restricted | 1 | 2005 | 39 | 0.060 |
Why?
|
| Risk Factors | 3 | 2016 | 9950 | 0.060 |
Why?
|
| Body Surface Area | 1 | 2005 | 31 | 0.060 |
Why?
|
| Prognosis | 3 | 2016 | 4503 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2007 | 224 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2005 | 89 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 5025 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 96 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 175 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2008 | 488 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2005 | 178 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 419 | 0.060 |
Why?
|
| ROC Curve | 1 | 2005 | 554 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2008 | 964 | 0.050 |
Why?
|
| Body Composition | 1 | 2005 | 479 | 0.050 |
Why?
|
| Random Allocation | 1 | 2003 | 417 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 743 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 2390 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 554 | 0.050 |
Why?
|
| Hospitalization | 1 | 2008 | 1731 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2012 | 15934 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 684 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2002 | 946 | 0.040 |
Why?
|
| Telephone | 1 | 2018 | 109 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2018 | 73 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 2104 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2003 | 1470 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 3342 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 1301 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2011 | 1473 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 1248 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2012 | 12083 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 514 | 0.030 |
Why?
|
| Adult | 3 | 2011 | 28944 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 606 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2016 | 3319 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 611 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 1834 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2012 | 70 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 1170 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1491 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 105 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 197 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1067 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 481 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1092 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 3040 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2007 | 47 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6216 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 277 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 868 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 1164 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 699 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 731 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 52 | 0.020 |
Why?
|
| Ligation | 1 | 2005 | 134 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2005 | 92 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 317 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2824 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1583 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2005 | 245 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2007 | 376 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 337 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1689 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 1881 | 0.010 |
Why?
|
| Aorta | 1 | 2005 | 540 | 0.010 |
Why?
|
| United States | 1 | 2016 | 10564 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6343 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 3257 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1592 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 2952 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 2443 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 5794 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 17647 | 0.000 |
Why?
|
| Animals | 1 | 2005 | 33923 | 0.000 |
Why?
|